Search Results 1741-1750 of 4032 for Solid
Screening or documented historical scintigraphy (within 3 years prior to screening) with approximately 10% or greater of solid contents retained at 4 hours.
The purpose of this study is to compare the objective response rate (ORR) by IRR of ripretinib vs sunitinib using modified Response Evaluation Criteria in Solid ...
... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. Expanded Access Study For The Treatment Of Patients With Commercially Out-of-Specification ...
At least one non-nodal lesion considered measurable by Response Evaluation Criteria in Solid Tumors (RECIST) criteria (that is, a lesion whose longest ...
History of a hematologic malignancy, malignant primary brain tumor, malignant sarcoma, or another malignant primary solid tumor, unless no evidence of that ...
A Study of the Safety, Tolerability, Drug/Body Interactions, Biological and Clinical Activity of MSB0011359C (M7824) in Metastatic or Locally Advanced Solid ...
Dose escalation (Part A) only: Patients with advanced or metastatic relapsed or refractory solid tumours of any histology with KRAS wt amplification or ...
Has undergone solid organ or hematopoietic stem cell transplantation. For enrollment in Stage 1 or 2: -The qualifying episode of CDI must meet all the ...
Advanced scaffold fabrication. 3D scaffolds fabricated using solid free-form fabrication techniques have controlled internal pore structures and pore ...
The purpose of this study is to evaluate the safety, tolerability, and preliminary effectiveness of HMPL-306 in advanced or metastatic solid tumors with IDH ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.